Back
ESC Premium Access

De-escalation of antiplatelet therapy after percutaneous coronary intervention in acute coronary syndrome patients: outcome of diabetics in the randomized TROPICAL-ACS trial

Session: Diabetes-associated coronary artery disease
Topic: Pharmacotherapy
Speaker: Doctor R. Hein (Munich, DE)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Ralph Hein

Municipal Hospital of Munich, Munich (Germany)
0 follower

6 more presentations in this session

Long-term safety and efficacy of the xience everolimus eluting stent in patients at high bleeding risk: a patient-level pooled analysis from four xience post-approval trials

Speaker: Doctor R. Mehran (New York, US)

Access
Abstract
Slides
Thumbnail

Diagnostic performance of quantitative flow ratio in diabetic and non-diabetic patients

Speaker: Mr J. Smit (Leiden, NL)

Access
Abstract
Slides
Thumbnail

A clinical risk score to predict the presence of obstructive coronary artery disease in asymptomatic patients with type 2 diabetes

Speaker: Assistant Professor C. Kim (Uijungbu, KR)

Access
Abstract
Slides
Thumbnail

Impact of glycated hemoglobin in diabetic patients with coronary artery disease undergoing surgery, angioplasty or clinical treatment in a very long-term follow-up

Speaker: Mr E. Martins (Sao Paulo, BR)

Access
Abstract
Slides
Thumbnail

Prognostic impact of admission hyperglycemia in acute coronary syndrome patients and its interaction with diabetes mellitus history and metabolic control.

Speaker: Doctor J. Alves Guimaraes (Vila Real, PT)

Access
Abstract
Slides
Thumbnail

Access the full session

Diabetes-associated coronary artery disease

Speakers: Doctor R. Hein, Doctor R. Mehran, Mr J. Smit, Assistant Professor C. Kim, Mr E. Martins...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb